07 Jan 2019

MEDTRONIC GETS OK TO STUDY PATIENTS WITH BICUSPID AORTIC VALUES USING COREVALVE EVOLUT TAVR SYSTEM

The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for Medtronic to initiate a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who are at low risk of surgical mortality. Medtronic separately received FDA approval for revised commercial

0
05 Jan 2019

WHEN MEDICINE MAKES PATIENTS SICKER

  By Sydney Lupkin Photos by Heidi de Marco Despite the jackhammer-like rhythm of a mechanical ventilator, Alicia Moreno had dozed off in a chair by her 1-year-old’s hospital bed, when a doctor woke her with some bad news: The common stool softener her son, Anderson, was given months earlier had been

0
05 Jan 2019

IT’S A LITTLE-KNOWN SECRET THAT PATIENTS CAN GET THOUSANDS OF DOLLARS DIRECTLY FROM A DRUGMAKER

      By Sarah Jane Tribble   Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Thousand Oaks, Calif.-based Amgen

0
03 Jan 2019

IN.PACT ADMIRAL:  MEDTRONIC SHARES FIVE-YEAR DRUG-COATED BALLOON DATA

  Medtronic plc data presented Nov. 12 reinforce the durability, safety, and effectiveness of the IN.PACT Admiral drug-coated balloon (DCB) in patients with peripheral artery disease in the superficial femoral and popliteal arteries. The five-year and final results from the pivotal IN.PACT SFA Trial and one-year all-subjects results from the

0
03 Jan 2019

KENNETH OSORIO, MD: A successful vein specialist leads missions of mercy to Caraz, Peru

  By John A. Chuback, MD, FACS, RPVI, RVT, RPhS   Kenneth Osorio, MD, is a successful phlebologist and the medical director of Advanced Vein Center, a very active clinical practice in Mesa, Arizona. Despite his many professional accomplishments, he has not forgotten his roots; nor has Dr. Osorio forgotten

0
03 Jan 2019

OFFICE MANAGERS CAN MAKE OR BREAK YOUR PRACTICE

  By Jeffrey Miller How important are your office managers? Important in any business, they are particularly valuable in healthcare. In fact, they can single handedly make the difference between your practice’s success and failure. An excerpt from the book “All In” drives this message home:   Recently, we worked

0
03 Jan 2019

TREATING TORTUOUS VEINS: ‘I have chosen not to treat my patients…by administering PCF’

  By Eric Wellons, MD As a physician who treats patients with varicose veins, I have a variety of tools at my disposal that can relieve the significant disability brought on by the symptoms of this common vascular condition, such as achiness and a “heavy” feeling in the legs. In

0
02 Jan 2019

MARVELS OF THE VEIN AND VASCULAR DIAGNOSTICS CENTER

By Javier Calderon, RVT Imagine if you or your close family member has struggled with pain for months, even years, with no relief. This constant pain, itching swelling and general feeling of heaviness in the lower legs can severely alter a person’s lifestyle and make life extremely miserable. Now imagine

0
02 Jan 2019

IMPROVING WISELY: COLLABORATION HELPS IDENTIFY, CUT HEALTHCARE WASTE

By Vanessa Salvia In the elegant Presidential Ballroom of the Gaylord Opryland Resort in Nashville, Martin “Marty” Makary, MD, addressed American College of Phlebology’s 32nd Annual Congress attendees eager to hear his message about how the program Improving Wisely is helping to reduce waste in healthcare. More than 1,200 registrants,

0
02 Jan 2019

BOSTON SCIENTIFIC ACQUIRES REST OF MILLIPEDE IN $4.8 BILLION YEAR-LONG SHOPPING SPREE

After a year of holding the option to acquire Millipede, Boston Scientific decided to do it a year before the option ran out. When the pair signed the agreement last January, Boston Scientific paid $90 million for a portion of the mitral regurgitation startup’s shares. Now, Boston Scientific is spending $325 million

0